Hill-Rom Holdings, Inc. (NYSE:HRC) – Equities researchers at KeyCorp increased their FY2019 EPS estimates for Hill-Rom in a research report issued to clients and investors on Wednesday. KeyCorp analyst M. Mishan now anticipates that the medical technology company will post earnings per share of $5.08 for the year, up from their prior estimate of $4.70. KeyCorp currently has a “Buy” rating and a $97.00 target price on the stock.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.27 by $0.05. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 earnings per share.
Shares of Hill-Rom (NYSE HRC) traded up $1.47 during trading on Friday, hitting $89.30. The stock had a trading volume of 512,759 shares, compared to its average volume of 417,146. The stock has a market capitalization of $5,880.00, a price-to-earnings ratio of 44.87, a P/E/G ratio of 1.56 and a beta of 1.19. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. Hill-Rom has a 1 year low of $57.18 and a 1 year high of $89.64.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Stifel Financial Corp boosted its holdings in Hill-Rom by 0.5% in the second quarter. Stifel Financial Corp now owns 4,379 shares of the medical technology company’s stock worth $349,000 after acquiring an additional 23 shares in the last quarter. ETRADE Capital Management LLC boosted its holdings in Hill-Rom by 4.6% in the second quarter. ETRADE Capital Management LLC now owns 6,940 shares of the medical technology company’s stock worth $552,000 after acquiring an additional 303 shares in the last quarter. Ameritas Investment Partners Inc. boosted its holdings in Hill-Rom by 2.2% in the second quarter. Ameritas Investment Partners Inc. now owns 17,910 shares of the medical technology company’s stock worth $1,426,000 after acquiring an additional 378 shares in the last quarter. Citigroup Inc. boosted its holdings in Hill-Rom by 21.1% in the second quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock worth $198,000 after acquiring an additional 433 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky boosted its holdings in Hill-Rom by 4.4% in the second quarter. Teachers Retirement System of The State of Kentucky now owns 11,750 shares of the medical technology company’s stock worth $935,000 after acquiring an additional 500 shares in the last quarter. 81.92% of the stock is owned by institutional investors and hedge funds.
In related news, CEO John J. Greisch sold 125,241 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $82.59, for a total transaction of $10,343,654.19. Following the sale, the chief executive officer now owns 280,851 shares of the company’s stock, valued at $23,195,484.09. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Paul Sherwood Johnson sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $82.99, for a total value of $82,990.00. Following the sale, the senior vice president now directly owns 1,066 shares in the company, valued at approximately $88,467.34. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 226,241 shares of company stock worth $18,708,644. 2.20% of the stock is owned by corporate insiders.
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date of this dividend was Thursday, December 14th. Hill-Rom’s payout ratio is currently 36.18%.
ILLEGAL ACTIVITY WARNING: “FY2019 Earnings Estimate for Hill-Rom Holdings, Inc. Issued By KeyCorp (HRC)” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2018/01/19/fy2019-earnings-estimate-for-hill-rom-holdings-inc-issued-by-keycorp-hrc.html.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.